29-Oct-2024 6:00 AM CST - Business Wire GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma GlycoMimetics, Inc. (NASDAQ: GLYC) announced today it has entered into an acquisition agreement with Crescent Biopharma, Inc. (Crescent), a privately held biotechnology company advancing a pipeline of oncology therapeutics designed to treat solid tumors. Upon completion of the transaction, the Company plans to operate under the name Crescent Biopharma, Inc. In support of the acquisition, a syndicate of investors led by Fairmount, Venrock Healthcare Capital Par
29-Oct-2024 6:00 AM CST - Business Wire GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma GlycoMimetics, Inc. (NASDAQ: GLYC) announced today it has entered into an acquisition agreement with Crescent Biopharma, Inc. (Crescent), a privately held biotechnology company advancing a pipeline of oncology therapeutics designed to treat solid tumors. Upon completion of the transaction, the Company plans to operate under the name Crescent Biopharma, Inc. In support of the acquisition, a syndicate of investors led by Fairmount, Venrock Healthcare Capital Par
